drugset / Trial / NCT00541775
Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to test the safety and effectiveness of sitagliptin in patients with type 2 diabetes.
Timeline
- Start
- 2006-06
- Primary completion
- 2007-03
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rosiglitazone | Small molecule | 8 mg | — |
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |
| Background | Metformin | Small molecule | 1500 mg | Oral |